Debocal500 mg+200 IU

Debocal is indicated for the prevention and treatment of calcium and vitamin D deficiency, and to support bone mineralization when dietary intake is insufficient.

Established / Guideline-Supported Uses

• Calcium and Vitamin D deficiency: Prevention and treatment of dietary calcium and vitamin D insufficiency in adults, adolescents, and the elderly.
• Osteoporosis (adjunct therapy): Debocal is used as an adjunct to specific osteoporosis treatment (e.g., bisphosphonates, hormone therapy) in postmenopausal women, elderly men, and patients on long-term corticosteroid therapy, since adequate calcium and vitamin D status is required for these therapies to work.
• Prevention of osteoporosis: Supplementation in individuals at risk of bone loss (postmenopausal women, elderly, prolonged immobilization) as part of a comprehensive bone-health regimen including diet and weight-bearing exercise.

Other Supportive Uses

• As a supplement during pregnancy and lactation when dietary intake is inadequate (only on physician advice; see Pregnancy and Lactation).
• Adjunct nutritional support in conditions of increased calcium/vitamin D requirement, such as certain malabsorption states, under medical supervision.

Debocal is not a substitute for disease-specific therapy in diagnosed metabolic bone disease and should be used as part of an overall treatment plan directed by a physician.

Elemental Calcium + Vitamin D3 is a combination nutritional supplement. Each dosage unit supplies a stated amount of elemental calcium (derived from a calcium salt such as calcium carbonate and/or calcium citrate) together with vitamin D3 (cholecalciferol).

Strength and the exact elemental calcium content per unit vary by brand and formulation (tablet, chewable tablet, or oral suspension); the label of the specific pack should always be checked for the exact elemental calcium (mg) and vitamin D3 (IU) content.

Debocal combines an essential mineral (calcium, expressed as elemental calcium) with vitamin D3, a fat-soluble vitamin that regulates calcium and phosphate metabolism. Calcium is the principal mineral component of bone and teeth and is required for normal muscle contraction, nerve conduction, and blood clotting. Vitamin D3 increases intestinal absorption of dietary calcium and phosphate and supports normal bone mineralization.

Debocal is widely used as an over-the-counter and physician-recommended supplement for maintaining bone health, particularly in populations with increased calcium/vitamin D requirements or reduced dietary intake, such as postmenopausal women, the elderly, and individuals with limited sun exposure.

Debocal belongs to the therapeutic class of mineral and vitamin supplements — specifically, calcium salts in combination with vitamin D and its analogues, used for bone metabolism and mineral homeostasis.

Mechanism: Elemental Calcium + Vitamin D3 works through the complementary actions of its two components.

• Calcium is the principal extracellular cation required for the formation of hydroxyapatite crystal, the mineral matrix of bone and teeth. It also plays essential roles in neuromuscular transmission, cardiac function, and the coagulation cascade.
• Vitamin D3 (cholecalciferol) is hydroxylated in the liver to 25-hydroxyvitamin D and then in the kidney to the active form, 1,25-dihydroxyvitamin D (calcitriol). Calcitriol increases active intestinal absorption of calcium and phosphate, promotes renal tubular reabsorption of calcium, and, together with parathyroid hormone, regulates bone remodeling.

By supplying both components together, Elemental Calcium + Vitamin D3 ensures that the ingested calcium is more efficiently absorbed and utilized than calcium given alone, particularly in individuals with suboptimal vitamin D status.

Debocal should be taken by mouth, preferably with meals to improve calcium absorption and minimize stomach upset. Chewable tablets must be chewed completely before swallowing; conventional tablets should be swallowed whole with water. If more than one dose per day is prescribed, doses should be spaced through the day rather than taken together, and separated by at least 2 hours from medicines known to interact with calcium.

Debocal should be used cautiously with the following medicines due to clinically significant interactions:

• Bisphosphonates (e.g., alendronate, risedronate): Calcium markedly reduces bisphosphonate absorption. Bisphosphonates should be taken at least 30-60 minutes before Debocal or any calcium-containing product.
• Tetracycline and fluoroquinolone antibiotics: Calcium forms insoluble chelates with these antibiotics, reducing their absorption and efficacy. Doses should be separated by at least 2-3 hours.
• Thyroid hormone (levothyroxine): Calcium reduces levothyroxine absorption; separate administration by at least 4 hours.
• Thiazide diuretics: Concurrent use with Debocal increases the risk of hypercalcemia due to reduced renal calcium excretion; calcium levels should be monitored.
• Corticosteroids: May reduce calcium absorption and increase requirements; concomitant use requires monitoring.
• Digoxin: Hypercalcemia arising from excessive intake of Debocal increases the risk of digoxin-induced cardiac arrhythmias.
• Other vitamin D or calcium-containing products: Concurrent use with other supplements or antacids containing calcium or vitamin D increases the risk of hypercalcemia and hypervitaminosis D; total combined intake from all sources should not exceed recommended limits.

Debocal is generally well tolerated at recommended doses. Reported adverse effects include:

• Common: Constipation, bloating, flatulence, mild abdominal discomfort, and nausea.
• Uncommon (usually with excessive/prolonged intake): Symptoms of hypercalcemia — anorexia, thirst, polyuria, muscle weakness, confusion; hypercalciuria; and, rarely, kidney stone formation.
• Rare: Allergic/hypersensitivity reactions such as skin rash or itching.

Patients should seek medical advice if persistent gastrointestinal symptoms occur or if symptoms suggestive of hypercalcemia develop while taking Debocal.

Calcium and vitamin D are required in increased amounts during pregnancy and lactation, and Debocal may be recommended by a physician when dietary intake is insufficient. However, doses should not exceed the recommended daily allowance for pregnant or lactating women, since excessive maternal vitamin D or calcium intake has been associated with risks to the mother and fetus/infant (including hypercalcemia).

Debocal should be used during pregnancy and lactation only if clearly needed and the recommended dose is not exceeded; use should be under medical supervision, with the potential benefit weighed against any potential risk. Patients should consult their physician before starting or continuing Debocal during pregnancy or breastfeeding.

• Renal impairment: Debocal should be used with caution in patients with impaired kidney function, as calcium and vitamin D handling is altered and the risk of hypercalcemia and soft-tissue calcification is increased; monitoring of serum calcium and renal function is advised.
• Cumulative intake: Total elemental calcium and vitamin D3 intake from Debocal, diet, and any other supplements or fortified foods should not exceed the recommended tolerable upper intake level, to avoid hypercalcemia and hypervitaminosis D.
• Concurrent thiazide diuretic use: Increases risk of hypercalcemia; monitor calcium levels (see Interactions).
• History of calcium-containing kidney stones: Use Debocal with caution and under medical advice, as supplemental calcium may theoretically increase urinary calcium excretion in susceptible individuals.
• Granulomatous disease or hyperparathyroidism: These conditions increase sensitivity to vitamin D and calcium; Debocal should be used only under close medical supervision.
• Drug spacing: To avoid reduced absorption of other medicines, Debocal should be taken at least 2-4 hours apart from bisphosphonates, tetracycline/fluoroquinolone antibiotics, and thyroid hormone (see Interactions).

Overdose or prolonged excessive intake of Debocal can cause hypercalcemia and hypervitaminosis D, with symptoms such as nausea, vomiting, constipation, abdominal pain, excessive thirst, frequent urination, muscle weakness, confusion, and, in severe cases, cardiac arrhythmias or kidney injury.

If overdose of Debocal is suspected, discontinue the product and seek immediate medical attention or contact a poison control center/emergency services. Management is supportive and should be carried out by qualified medical personnel; do not attempt specific home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Elderly: Debocal is commonly used in elderly patients for bone health maintenance and osteoporosis prevention; standard doses are generally appropriate, with attention to renal function and concurrent medications.
• Renal impairment: Use with caution; risk of hypercalcemia is increased (see Precautions and Warnings).
• Hepatic impairment: No specific dose adjustment is established; vitamin D activation may be affected in significant hepatic disease, and use should be individualized by a physician.
• Pediatric population: See Pediatric Uses.
• Pregnancy and lactation: See Pregnancy and Lactation section.

Duration of Debocal therapy depends on the indication: for correction of confirmed calcium or vitamin D deficiency, treatment is usually continued for several weeks to a few months with reassessment of levels; when used as an adjunct in osteoporosis prevention or treatment, Debocal is typically continued long-term, for as long as the underlying risk factors persist and as directed by the treating physician.

Elemental Calcium + Vitamin D3 falls under the drug/supplement classes: Mineral supplements (calcium salts) and Vitamin D analogues/derivatives, used in combination for bone and mineral metabolism.

Elemental Calcium + Vitamin D3 acts by supplying elemental calcium, the principal mineral required for bone matrix mineralization and for normal neuromuscular and cardiac function, together with vitamin D3, which is converted in the body to its active hormonal form and thereby increases intestinal absorption of calcium and phosphate, promotes renal calcium reabsorption, and supports coordinated bone remodeling with parathyroid hormone.

Debocal may be used in children and adolescents for the prevention or treatment of dietary calcium and vitamin D deficiency, using age-appropriate formulations (e.g., chewable tablets) and weight/age-based dosing as recommended by a pediatrician.

Safety and efficacy of specific Debocal products have not been established for all pediatric age groups and strengths; the product label and a pediatrician's guidance should be followed. Doses should not exceed age-appropriate recommended daily allowances for calcium and vitamin D, as excessive intake in children can also cause hypercalcemia.